{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-21-018623","form_type":"8-K","ticker":"SKYE","cik":"0001516551","company_name":"Skye Bioscience, Inc.","filed_at":"2021-09-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.355905+00:00","generated_at":"2026-06-29T03:30:34.781977+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Skye Bioscience terminates RoseRyan; Principal Accounting Officer Janney resigns","bullets":["Terminated RoseRyan engagement as of Sept 14, 2021; Richard Janney resigned as Principal Accounting Officer.","CEO Punit Dhillon will serve as principal accounting officer until successor is appointed.","Company moved to new office at 11250 El Camino Real, San Diego, leasing approx. 2,645 sq ft from ROIC California."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-21-018623","json":"https://secwatch.observer/filing/0001628280-21-018623.json","markdown":"https://secwatch.observer/filing/0001628280-21-018623.md","text":"https://secwatch.observer/filing/0001628280-21-018623.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1516551/000162828021018623/0001628280-21-018623-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1516551/000162828021018623/skye-20210914.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T03:30:34.781977+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"484ae77aa4","claim":"Richard Janney resigned as Principal Accounting Officer at Skye Bioscience, Inc..","evidence_excerpt":"As such, Richard Janney, the Company's Principal Accounting Officer engaged through RoseRyan, has tendered his resignation with the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1516551/000162828021018623/0001628280-21-018623-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Principal Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"695f79df0b","claim":"Punit Dhillon changed role as Principal Accounting Officer at Skye Bioscience, Inc..","evidence_excerpt":"Punit Dhillon, Chief Executive Officer, President, Secretary, Chair of the Board, and Director of the Company, will serve as the principal accounting officer until a successor is appointed.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1516551/000162828021018623/0001628280-21-018623-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will serve as"},{"label":"Role","value":"Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}